In 2005, PCI expanded its manufacturing facilities by acquiring its current site in Newburyport, Massachusetts. The facility had its most recent successful cGMP inspection by the FDA in April 2015.
PCI has the capabilities to support API manufacturing from pre-clinical development to commercial production all within one organization.
In 2003, PCI Synthesis expanded its facilities by opening an API development facility in Devens, Massachusetts. This state-of-the-art facility houses our Research & Development and Chemical Synthesis Laboratories for small-scale development and production.